WCM Investment Management
RCKT icon

WCM Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

WCM Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-285,665
Closed -$5.27M – 319
2024
Q3 		$5.27M Sell
285,665
-7,236
-2% -$148K 0.01% 166
2024
Q2 		$6.28M Sell
292,901
-4,757
-2% -$109K 0.01% 156
2024
Q1 		$8.02M Buy
297,658
+1,645
+0.6% +$46.7K 0.02% 148
2023
Q4 		$9.15M Buy
296,013
+7,212
+2% +$159K 0.03% 144
2023
Q3 		$5.89M Buy
288,801
+5,867
+2% +$107K 0.02% 147
2023
Q2 		$5.62M Buy
282,934
+29,123
+11% +$588K 0.02% 151
2023
Q1 		$4.35M Buy
253,811
+2,113
+0.8% +$41.4K 0.01% 159
2022
Q4 		$4.93M Sell
251,698
-139,232
-36% -$2.56M 0.02% 160
2022
Q3 		$5.49M Buy
390,930
+20,181
+5% +$315K 0.02% 147
2022
Q2 		$4.83M Buy
370,749
+163,575
+79% +$1.95M 0.02% 149
2022
Q1 		$3.29M Buy
207,174
+14,245
+7% +$246K 0.01% 155
2021
Q4 		$4.21M Buy
192,929
+95,664
+98% +$2.61M 0.01% 156
2021
Q3 		$2.91M Buy
97,265
+464
+0.5% +$16.9K 0.01% 162
2021
Q2 		$4.29M Buy
96,801
+3,811
+4% +$166K 0.01% 141
2021
Q1 		$4.13M Sell
92,990
-2,145
-2% -$118K 0.01% 141
2020
Q4 		$5.22M Buy
+95,135
New +$3.47M 0.01% 143

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WCM Investment Management's RCKT Position: Q4 2024 in Review

WCM Investment Management sold out of Rocket Pharmaceuticals (RCKT) in Q4 2024, closing a stake of 285,665 shares — an estimated $5.27M sold.

WCM Investment Management first reported a position in RCKT in Q4 2020 and held it in 16 quarters. The position peaked at $9.15M in Q4 2023. 225 funds tracked by Wall St. Rank hold RCKT as of Q4 2024.

  • WCM Investment Management reported no remaining Rocket Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • WCM Investment Management sold 285,665 Rocket Pharmaceuticals shares in Q4 2024, an estimated $5.27M.
  • WCM Investment Management first reported a position in Rocket Pharmaceuticals in Q4 2020 and held it in 16 quarters.
  • WCM Investment Management's Rocket Pharmaceuticals position peaked at $9.15M in Q4 2023.
  • 225 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q4 2024.

Based on WCM Investment Management's 13F filing for Q4 2024, filed 28 Jan 2025.